Quote
—
—
No scored catalysts in the window yet.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-ltd.-announces-non-brokered-private-placement-1206470 · 8/12/2026+0.40
https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-announces-proposed-shares-for-debt-transaction-1172642 · 6/2/2026+0.20
https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-ltd.-announces-non-brokered-private-placement-1156703 · 4/11/2026+0.60
https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-completes-debt-settlement-to-improve-balance-sheet-1091411 · 10/24/2025+0.60
https://www.newsfilecorp.com/release/265683/Lobe-Sciences-Ltd.-to-Attend-the-ArcStoneKingswood-Growth-Summit-2025-in-Toronto · 9/16/2025+1.00
https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-announces-the-appointment-of-marco-mastrodonato-to-its-board-of-directo-1069778 · 9/9/2025+1.00
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
